How to successfully deal with a micromanaging boss
Plus: Don’t Short Yourself has some exciting news.
Plus: Don’t Short Yourself has some exciting news.
High risk warning: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all your initial investment; do not…
“Mr. McSevney raised millions from investors for what was presented as a mortgage investment corporation but most of those funds were not invested as promised,” Lysyk said. “This has no place in Ontario, and this outcome reinforces our commitment to protecting the integrity of our capital markets.” McSevney’s matter returns to court on September 8,…
Millions of Americans tap their smartphone screens daily to order rides, groceries, or dinner, hooked on the seamless convenience of the gig economy. Yet beneath this frictionless interface lies a brewing war. On one side, consumers are squeezed by volatile and erratic surge pricing, which adjusts to reflect spiking demand or dropping supply. On the…
Notice to Pension Funds, Asset Managers, and Fiduciaries Holding GeneDx Holdings Corp. (WGS) Shares: $33.42 Per-Share Decline Raises Fiduciary Evaluation Obligations NEW YORK, July 15, 2026 /PRNewswire/ — Institutional investors holding positions in GeneDx Holdings Corp. (NASDAQ: WGS) during the period from April 16, 2025 through May 4, 2026 may wish to evaluate lead plaintiff…
Most of us enjoy a good comeback story, and that’s exactly what Stellantis (STLA 5.40%) hopes to achieve by the end of this decade. The struggling carmaker is putting its money where its mouth is with a $70 billion turnaround strategy that focuses not just on North America, but Europe as well, through a multipronged…
Curative CEO and founder Fred Turner believes in the SaaSpocalypse. During an interview on the “20VC with Harry Stebbings” podcast, the health insurance executive was asked whether he bought the theory that software-as-a-service was dying. “Yes,” Turner said, bluntly. When asked why, he said, “I see the number of contracts that we’re canceling. We just…